Sylvaine Artero Inserm researcher Unit 1061 Neuropsychiatry: Epidemiological and Clinical Research +33 (0)4 99 61 45 68 firstname.lastname@example.org
While genetic predisposition is a major factor in the risk of developing age-related dementia, and Alzheimer’s disease in particular, environmental factors such as diet also have an important role to play. Thanks to the 12-year follow-up of nearly 2,800 French people over the age of 65, a research team from Unit 1061 Neuropsychiatry: Epidemiological and Clinical Research (Inserm/Université de Montpellier) has sought to understand the impact of meals high in sugars (simple sugars and refined carbohydrates) on the risk of developing dementia. Its research shows a link between the consumption of sugars during the afternoon snack and the risk of developing Alzheimer’s disease in people with genetic predispositions. These results published in Alzheimer’s and Dementia pave the way for a better understanding of the links between environmental and genetic risk factors and could lead to improved dementia prevention strategies.
According to WHO forecasts, more than 152 million people could be affected by age-related dementia by 2050. There is currently no treatment to cure or slow the progression of these conditions, which include Alzheimer’s disease. It is therefore essential to identify the factors favoring their development and on which it would be possible to take preventive action.
For several years now, nutrition has been recognized as an important factor in good brain aging. In particular, several animal studies have emphasized the role of a high intake of sugars – which include starch and added sugars (glucose and fructose syrups, sucrose) – in aggravating the clinical signs of Alzheimer’s disease and, in particular, in accelerating the appearance of amyloid deposits (senile plaques) characteristic of Alzheimer’s disease.
However, until now, no human studies had explored a potential link between genetic predisposition, the consumption of sugars, and the risk of dementia.
A team led by Inserm researcher Sylvaine Artero in Unit 1061 Neuropsychiatry: Epidemiological and Clinical Research (Inserm/Université de Montpellier) wished to highlight the links between the onset of dementia (in particular Alzheimer’s disease) in humans, genetic predispositions linked to the E4 allele, and the consumption of sugars. They analyzed 12 years of data from nearly 2,800 participants in the French Three-City Study, which has been following nearly 10,000 French people over 65 years of age since 1999. They studied the development of 350 cases of dementia related to eating habits and more specifically their contribution to glycemic load (the ability of a food to raise blood glucose levels according to the portion consumed) estimated over four meals: breakfast, lunch, afternoon snack, and dinner.
But why would the consumption of sugars during the afternoon snack have a greater impact on people with genetic predispositions?
Indeed, it has already been shown in animals that carriers of the E4 allele had a less efficient glucose metabolism. They would therefore be more likely to develop insulin resistance. However, the sugary foods consumed during the afternoon snack tend to be low in fat and fiber. They are eaten more quickly and without being accompanied by other types of food, such as at main meals. As a result, they are absorbed into the bloodstream much faster during digestion, triggering a peak in insulin.
“Repeated daily, these insulin peaks could eventually lead to peripheral insulin resistance but also to cerebral insulin resistance (in which the brain is less sensitive to insulin and less able to use glucose) via oxidative stress and inflammation, which would encourage the development of dementia, phenomena to which E4 allele carriers are more sensitive,” says Artero.
“These results pave the way for new prevention strategies but need to be confirmed by other population-based studies and further investigated by experimental studies in order to better understand the links between sugar consumption, insulin resistance and the development of dementia,” concludes Artero.
Inserm researchers at I-Stem – the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases – report encouraging results with metformin, a known diabetes drug, for the symptomatic treatment of Steinert myotonic dystrophy. A phase II trial conducted in 40 patients at ...
Huntington's disease is a genetic neurological condition that usually manifests in adulthood. Teams of researchers and clinicians from Inserm, Université Grenoble Alpes, Sorbonne Université, CNRS and AP-HP at the Grenoble Institute of Neuroscience and the Brain Institute, have discovered abnormalities in the ...
Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer’s disease in apolipoprotein E 𝜺4 allele carriers Mélissa Gentreau1, Virginie Chuy2, Catherine Féart2, Cécilia Samieri2, Karen Ritchie1, Michel Raymond3, Claire Berticat3, Sylvaine Artero1 1 Neuropsychiatry: Epidemiological & Clinical Research, University of Montpellier, Inserm, Montpellier, France 2 Bordeaux Population Health Research Centre, University of Bordeaux, Inserm, Bordeaux, France 3 ISEM, University of Montpellier, CNRS, EPHE, IRD, Montpellier, France *Claire Berticat and Sylvaine Artero contributed equally to this work. Alzheimer’s and Dementia: https://doi.org/10.1002/alz.12114